Dynatrace Inc (DT) concluded trading on Thursday at a closing price of $51.06, with 4.52 million shares of worth about $230.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.87% during that period and on January 16, 2025 the price saw a gain of about 1.07%. Currently the company’s common shares owned by public are about 298.52M shares, out of which, 294.77M shares are available for trading.
Stock saw a price change of -2.24% in past 5 days and over the past one month there was a price change of -6.16%. Year-to-date (YTD), DT shares are showing a performance of -6.05% which decreased to -8.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $39.42 but also hit the highest price of $61.41 during that period. The average intraday trading volume for Dynatrace Inc shares is 2.97 million. The stock is currently trading -4.21% below its 20-day simple moving average (SMA20), while that difference is down -6.07% for SMA50 and it goes to 2.99% higher than SMA200.
Dynatrace Inc (NYSE: DT) currently have 298.52M outstanding shares and institutions hold larger chunk of about 96.45% of that.
The stock has a current market capitalization of $15.24B and its 3Y-monthly beta is at 1.04. PE ratio of stock for trailing 12 months is 94.02, while it has posted earnings per share of $0.54 in the same period. Its PEG reads 7.21 and has Quick Ratio of 1.31 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for DT, volatility over the week remained 2.11% while standing at 2.32% over the month.
Stock’s fiscal year EPS is expected to rise by 10.38% while it is estimated to increase by 13.69% in next year.
Coverage by UBS stated Dynatrace Inc (DT) stock as a Neutral in their note to investors on November 27, 2024, suggesting a price target of $58 for the stock. On November 08, 2024, BMO Capital Markets Reiterated their recommendations, while on October 17, 2024, Wedbush Resumed their ratings for the stock with a price target of $67. Stock get a Neutral rating from Exane BNP Paribas on October 08, 2024.
